CEL SCI Corp (CVM) stock

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$1.19−0.12 (-9.16%)

Close on Nov 12, 2026Market cap $20.93MP/E –Yield –

Cel Sci total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Cel Sci's total debt was $7.96M at Sep 30, 2025. For fiscal 2025 it was $7.96M.

Period	Period end	Value	Change
FY2025	Sep 30, 2025	$7.96M	–

Change is against the same quarter a year earlier.

Periods

Period	Period end	Value	Change
Q4 FY2025CQ3 2025	Sep 30, 2025	$7.96M	–

See a number that looks wrong?